AbbVie
ABBV
ABBV
1,604 hedge funds and large institutions have $73.6B invested in AbbVie in 2014 Q4 according to their latest regulatory filings, with 200 funds opening new positions, 546 increasing their positions, 662 reducing their positions, and 83 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
1% more capital invested
Capital invested by funds: $72.7B → $73.6B (+$899M)
8.54% less ownership
Funds ownership: 79.06% → 70.51% (-8.5%)
18% less repeat investments, than reductions
Existing positions increased: 546 | Existing positions reduced: 662
Holders
1,604
Holding in Top 10
94
Calls
$1.15B
Puts
$678M
Top Buyers
| 1 | +$246M | |
| 2 | +$213M | |
| 3 | +$186M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$182M |
| 5 |
Capital World Investors
Los Angeles,
California
|
+$155M |
Top Sellers
| 1 | -$2.98B | |
| 2 | -$963M | |
| 3 | -$758M | |
| 4 |
PC
Paulson & Co
New York
|
-$751M |
| 5 |
Viking Global Investors
Stamford,
Connecticut
|
-$622M |